Amino acid supplement and exercise for people on dialysis
Part of Brain & nervous system clinical trials.
This trial studies whether taking essential amino acids along with exercise can improve muscle function in people receiving hemodialysis. It may help you build or maintain strength and mobility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You receive hemodialysis (a dialysis treatment done through a machine).
- You live in the community (not in a long-term care facility).
- You can walk more than 100 meters, with or without a walking aid.
- You are not currently dealing with cancer.
- You are not pregnant.
- You do not have certain serious gut absorption problems or past surgery of the small intestine or colon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether exercise during hemodialysis can improve muscle oxygen levels and how well dialysis works. It is for people who have been on dialysis for at least a year and have muscle loss (sarcopenia).
This study tests a special amino acid supplement to see if it can help improve muscle strength and function in people with advanced chronic kidney disease (CKD) who have low hand grip strength, often a sign of muscle loss. It may offer a way to preserve muscle health without dialysis.
This trial tests if a supervised exercise program can help people on dialysis who have muscle wasting (uremic sarcopenia). It aims to improve muscle strength, physical function, and quality of life.
This study tests if gentle exercise during your dialysis sessions can help maintain muscle strength and improve sleep. If you are on chronic hemodialysis, at least 40 years old, and able to do simple exercises safely, you may be eligible.
This trial is for adults with chronic kidney disease and low muscle strength (sarcopenia). It aims to find ways to improve outcomes, especially if you have a higher risk of complications.
This trial tests whether a drug called roxadustat can help treat muscle loss (sarcopenia) in people on hemodialysis. It aims to see if improving anemia also strengthens muscles.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.